# Lisdexamfetamine Dimesylate

NDC: 0406-5124
Generic name: Lisdexamfetamine Dimesylate
Labeler / Manufacturer: SpecGx LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20241217

FDA application: ANDA218850

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0406-5124"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0406-5124
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a79b2ab-4131-4978-99a0-0119df57d5fe